Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
Oncotarget|October 22, 2021
Luminescence complementation technology for the identification of MYC:TRRAP inhibitorsEdmond J Feris, John W Hinds, Michael D ColePlos One|December 3, 2019
Formation of a structurally-stable conformation by the intrinsically disordered MYC:TRRAP complexEdmond J Feris, John W Hinds, Michael D ColePlos One|August 26, 2022
S146L in MYC is a context-dependent activating substitution in cancer developmentJohn W Hinds, Edmond J Feris, Owen M Wilkins, et al.Cancer Biology & Therapy|February 19, 2016
Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105Darcy Bates, Edmond J Feris, Alexey V Danilov, et al.ACS Pharmacology & Translational Science|August 23, 2021
Inhibition of Protein Synthesis Induced by CHK1 Inhibitors Discriminates Sensitive from Resistant Cancer CellsJohn W Hinds, Jennifer P Ditano, Alan EastmanCold Spring Harbor Perspectives in Medicine|July 3, 2014
MYC association with cancer risk and a new model of MYC-mediated repressionMichael D ColeCancer Research|November 9, 2012
MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferaseMandeep Kaur, Michael D ColeCritical Reviews in Biomedical Engineering|March 4, 2014
Vibration arthrometry: a critical reviewSteven C Abbott, Michael D ColeCell Cycle (Georgetown, Tex.)|April 4, 2007
HATs off to capping: a new mechanism for MycVictoria H Cowling, Michael D ColePageof 7